Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]

Authors:
  • JTJoseph Tkacz
    Joseph Tkacz
  • JSJill Schinkel
    Jill Schinkel
  • BLBenjamin Lewing
    Benjamin Lewing
  • BABarnabie Agatep
    Barnabie Agatep
  • SSSean Swisher
    Sean Swisher
  • SPSushma Patel
    Sushma Patel
  • DEDevechio Edwards
    Devechio Edwards
  • DTDaniel R Touchette
    Daniel R Touchette
  • EPEdward Portillo
    Edward Portillo
  • NFNorbert Feigler
    Norbert Feigler

Abstract
Corrigendum for the article Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study